Cystic Fibrosis 2023: Cystic Fibrosis- Disease and Advanced Drug Delivery Systems |
Submission link | https://easychair.org/conferences/?conf=cysticfibrosis2023 |
Abstract registration deadline | May 31, 2023 |
Submission deadline | September 30, 2023 |
About the Book
Cystic fibrosis was fatal uniformly and can only be detected during autopsy. Over the years technology developed and means of diagnosis were developed for cystic fibrosis. One of the major benchmarks was the sweat test which enabled greater accuracy for diagnosis. This was beginning to understand some pathophysiological aspects of this disease.
This book explores and compiles the current situation with generally utilized symptoms-based formulations and all possible routes to improve therapeutic benefit. Preparation methods of gene therapy and their physicochemical properties alongside application portrayal angles and impacts of them aspects on drug conveyance frameworks conduct in-vitro and in-vivo. The book will cover cystic fibrosis frameworks utilization in the field of controlled, bioavailable and delivery of complex molecules to improved clinical viability.
Submission Guidelines
All papers must be original and not simultaneously submitted to another journal, book or conference.
List of Topics
Table of Contents (Tentative):
-
Introduction to Cystic Fibrosis
-
Pathophysiological Aspects of CF
-
Diagnostic tools for CF
-
CFTR gene regulation in the etiology of CF
-
Role of microorganisms for causing cystic fibrosis
-
Advanced management of cystic fibrosis
-
Anti-inflammatory agents used in cystic fibrosis
-
Conventional therapies and their limitations
-
Challenges for development of formulation
-
Aerosol antibiotics in management of cystic fibrosis
-
Novel therapeutic approaches for the CF
-
Lipid Nanoparticles in treating cystic fibrosis
-
Liposomes in treating cystic fibrosis
-
Polymeric Nanoparticles in treating cystic fibrosis
-
Nanomedicine for Cystic Fibrosis
-
Role of stem and gene therapy in cystic fibrosis
-
Biomarkers for cystic fibrosis drug development
-
An update on Precision medicine in cystic fibrosis
-
Recent clinical trials ongoing for cystic fibrosis
-
Regulations for the monitoring and management of CF (Various regulatory agencies)
Editors
- Dr. Bhupendra Prajapati, Professor, Shree S.K.Patel College of Pharmaceutical Education and Research, Ganpat University, Gujarat, India (Email: bhupen27@gmail.com)
- Dr. Rishabha Malviya, Associate Professor, Galgotias University, India.
- Prof. Sonali Sundram, Assistant Professor, Galgotias University, India.
- Prof. Akshay Parihar, Assistant Professor, Faculty of Pharmaceutical Sciences, The ICFAI University, Baddi, Himachal Pradesh, India.
Publication
Cystic Fibrosis 2023 will be published by Apple Academic Press/ Taylor and Francis Group.
Contact
All questions about submissions should be emailed to Dr. Bhupendra Prajapati at "bhupen27@gmail.com, editor.rishabha@gmail.com". Contact No. +91-9429225025, +91-9450352185 (for whatsapp only)
Important dates
Abstract submission (approx. 500 words): 20 May 2023
Abstract acceptance notification: 25 May 2023
Full chapter submission: 30 July 2023
Review notification of chapter: 10 August 2023
Revise chapter submission: 20 August 2023
Publication/processing fee
Zero publication/processing fee.